Address And Details

82 Devonshire St , Boston, MA 02109
Fund Manager Team Managed
Manager Tenure

Strategy And Objective

The fund seeks capital appreciation. Normally investing primarily in non-U.S. securities, including securities of issuers located in emerging markets. Normally investing at least 80% of assets in securities of companies with small market capitalizations (which, for purposes of this fund, are those companies with market capitalizations of $5 billion or less).Normally investing primarily in common stocks. Allocating investments across different countries and regions. Using fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments.

Net Asset Value

as of 5:13 PM ET 09/24/2021

Performance

  • 1 Week
  • -1.36%
  • 1 Month
  • +2.88%
  • 3 Months
  • +10.39%
  • 1 Yr Return
  • +41.94%
  • 5 Yr Return
  • +58.05%

Equity Sector Breakdown

IndustrialCyclical 19.19%
RetailTrade 18.64%
Finance 14.34%
Technology 7.62%
Services 7.55%
NonDurables 5.66%
ConsumerDurables 4.82%
Health 3.76%
Energy 1.03%
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Stocks 89.47%
ForeignStocks 84.73%
Other 7.40%
Preferred 1.39%
Cash 0.00%
Bonds 0.00%
Convertible 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 4.94 B

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha 0.66 0.38 -1.41
Beta 0.88 0.84 0.87
R Squared 0.86 0.74 0.71
Std Deviation 17.65 14.71 13.84
Sharpe Ratio 0.97 1.05 n/a

Purchase Information

as of 5:22 PM ET 09/23/2021
Minimum Initial $0
Minimum Additional $0
Minimum Initial IRA $0

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +40.13%
  • +40.55%
+40.13% +40.55%
3 Year
  • +16.65%
  • +12.92%
+16.65% +12.92%
10 Year
  • +12.37%
  • +10.44%
+12.37% +10.44%
Life Of Fund
  • +11.84%
  • +11.14%
+11.84% +11.14%

Top 10 Holdings

Symbol Company Name % Of Assets
SCZ ISHARES MSCI EAFE SM CAP IDX 4.27%
6920 LASERTEC CORP 3.72%
VFWSX VANGUARD FTSE ALL WORLD EX-US 3.13%
ADDTB:SS ADDTECH AB 2.73%
6845 AZBIL CORP 2.61%
4684.T OBIC CO., LTD. 2.61%
ALIF ADDLIFE AB 2.61%
SPX.L SPIRAX SARCO ENGINEERING PLC 2.43%
DPH.L DECHRA PHARMACEUTICALS PLC 2.37%
SXS.L ~SPECTRIS PLC 2.30%

Recent Articles from TheStreet

Nikola

Tim Collins on How to Trade Nikola

Technical setups and short interest make much hated name volatile, and therefore interesting.

Chinese Firms Should Face Faster US Stock Delisting Over Audit Rules, SEC Chairman Gary Gensler Tells Lawmakers

Jim Cramer: Gensler's Plate is Very Full

SEC Chairman is key player in efforts to rein in ceaseless financial engineering.

stocks rise asset management sh

Cramer's Mad Money Recap: Advanced Micro Devices, Nvidia, Thor

Jim Cramer has your game plan for next week, which he says will be the calm before the earnings season storm.

Jim Cramer: Starbucks Needs More Traffic in Stores

Starbucks Resists Union Effort in New York Region: Report

Starbucks reportedly said it will raise wages and benefits and a union isn’t needed, to employees at three stores in Buffalo New York.

Exxon Mobil

Exxon, Occidental, Baker Hughes Make Goldman Turnaround List

Exxon has 'reduced costs, surprised to the downside on capital spending, outperformed our expectations in downstream/chemicals,' Goldman said.

videoblocks-a-series-of-fullhd-close-up-rotating-slider-dollymacro-shots-of-the-surface-of-computer-hardware-parts-chipsmotherboardcpucurcuits-close-up-macro-computer-chips-circuits-surface-rotating-dolly_s_mt0i43g_1080__D

Jim Cramer is Tired of the Weak Response to Chip Shortages

Companies need to forget about help from Washington and step up to the plate.

Microsoft Lead

Why 'Sarge' Guilfoyle Isn't Selling His Microsoft

Sharp management and strength across its business lines are keys to software giant.

Why Charles River Labs Is the Biotech Stock to Buy: Jim Cramer

Bret Jensen: Paratek Deal Shows Promise

While antibiotics are usually less profitable and slower to develop market share than other drugs, Paratek has a key factor in its favor.

Stocks Close Higher as Wall Street Dissects New Tax Laws

Stocks End Mixed Amid Evergrande Default Saga, Supply Chain Chaos

Evergrande's default saga, as well as mounting supply chain issues, have stocks trading mixed Friday.

bitcoin copy

Stock Market Today With Jim Cramer: China's Crypto Clampdown

Jim Cramer discusses China's crypto clampdown and Nike's report.